Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients.
about
Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation.Relapsed childhood acute myeloid leukemia patient with inversion of chromosome 16 harboring a low FLT3 internal tandem duplication allelic burden and KIT mutations.The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era.
P2860
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Postremission sequential monit ...... ute myeloid leukemia patients.
@ast
Postremission sequential monit ...... ute myeloid leukemia patients.
@en
type
label
Postremission sequential monit ...... ute myeloid leukemia patients.
@ast
Postremission sequential monit ...... ute myeloid leukemia patients.
@en
prefLabel
Postremission sequential monit ...... ute myeloid leukemia patients.
@ast
Postremission sequential monit ...... ute myeloid leukemia patients.
@en
P2093
P2860
P356
P1433
P1476
Postremission sequential monit ...... cute myeloid leukemia patients
@en
P2093
Angela Passi
Chiara Cattaneo
Chiara Pagani
Cinzia Lamorgese
Cristina Skert
Domenico Russo
Elisa Cerqui
Enrico Morello
Erika Borlenghi
Federica Cattina
P2860
P304
P356
10.1002/CAM4.593
P407
P577
2015-12-29T00:00:00Z